Autoimmune gastritis is a chronic condition in which the immune system attacks the acid-producing cells of the stomach, gradually destroying them and setting off a cascade of nutrient deficiencies, digestive problems, and long-term cancer risk. It affects women roughly twice as often as men, and the median delay from first symptoms to diagnosis sits at about 14 months, though misdiagnosed patients can wait years. The disease is more common and more consequential than most people realize, partly because its earliest sign is often plain iron deficiency rather than any obvious stomach complaint.
What the Immune System Actually Attacks
The stomach lining contains specialized parietal cells concentrated in the upper portion of the stomach, called the corpus and fundus. These cells do two critical jobs: they pump out hydrochloric acid (using an enzyme called the H+/K+ ATPase proton pump), and they secrete intrinsic factor, a protein you need to absorb vitamin B12. In autoimmune gastritis, immune cells specifically target that proton pump enzyme on the surface of parietal cells, triggering inflammation and progressive destruction of the cells themselves.1PubMed Central. Autoimmune gastritis, with or without pernicious anemia: epidemiology, risk factors, and clinical management The attack is driven primarily by a subset of T cells that recognize the proton pump as foreign, activating B cells to produce antibodies against parietal cells.2PubMed. H(+),K(+)-atpase (proton pump) is the target autoantigen of Th1-type cytotoxic T cells in autoimmune gastritis
Because parietal cells are concentrated in the corpus and fundus, the inflammation and damage are restricted to that region, leaving the lower portion of the stomach (the antrum) relatively unaffected in classical cases.3PubMed Central. Autoimmune gastritis: Pathologist’s viewpoint As more parietal cells are lost, acid production drops. When it drops far enough, you get a state called hypochlorhydria or, in severe cases, achlorhydria, meaning the stomach produces little to no acid at all. That low-acid environment is the root of most of the disease’s downstream effects.
Iron Deficiency Comes First, Then B12
If you picture autoimmune gastritis as eventually causing pernicious anemia from lack of B12, you are picturing the late stage. The early stage usually looks different. Because stomach acid is needed to release iron from food so it can be absorbed, iron deficiency is typically the first nutritional problem to appear. The body’s iron stores are smaller than its B12 reserves, so they deplete faster.4PubMed Central. Autoimmune gastritis, with or without pernicious anemia: epidemiology, risk factors, and clinical management – Section: Clinical manifestations This is one reason the disease is so often missed early on: a young woman with unexplained iron-deficiency anemia may be told to take iron supplements and sent on her way, without anyone thinking to look at her stomach.5PubMed Central. Autoimmune gastritis
Vitamin B12 deficiency develops later, sometimes years later, as intrinsic factor secretion declines along with the parietal cell mass. When B12 drops low enough, it can cause pernicious anemia, a form of megaloblastic anemia in which red blood cells are abnormally large and fewer in number. Left untreated, severe B12 deficiency can damage the spinal cord and peripheral nerves. One well-documented complication is subacute combined degeneration of the spinal cord, in which the protective myelin coating on nerve fibers breaks down. Treatment for B12 deficiency caused by autoimmune gastritis is lifelong, whether delivered by injection or high-dose oral supplementation.6PubMed Central. A case report: subacute combined degeneration of the spinal cord and pernicious anemia caused by autoimmune gastritis
Who Gets Autoimmune Gastritis
Women outnumber men by about 2 to 1. A study of nearly 300 patients found a female-to-male ratio of 2.3:1, with the average age at diagnosis around 61.7PubMed. Determinants of diagnostic delay in autoimmune atrophic gastritis The clinical picture also differs between men and women: women more often present with iron-deficiency anemia and coexisting autoimmune thyroid disease, while men tend to present later with pernicious anemia and are more likely to be overweight smokers.8PubMed. Gender-sex differences in autoimmune atrophic gastritis
Diagnostic delay is a real problem. The median delay is about 14 months, but for patients who receive a wrong initial diagnosis, it stretches to a median of 36 months, and women experience longer delays than men. Having a history of infertility or miscarriages was also associated with longer delays, hinting that iron and B12 deficiency may have been quietly affecting reproductive health before anyone connected it to the stomach.9PubMed. Determinants of diagnostic delay in autoimmune atrophic gastritis
Blood Tests That Point Toward a Diagnosis
Autoimmune gastritis cannot be definitively diagnosed by blood work alone, since biopsy remains the gold standard, but several blood markers can strongly suggest it and help decide who needs an endoscopy.
Parietal cell antibodies (specifically, antibodies targeting the H+/K+ ATPase) are considered a hallmark serological marker. Newer assay methods that use purified proton pump protein perform better than older indirect immunofluorescence testing, offering higher sensitivity for screening.10PubMed Central. Improving the Diagnosis of Autoimmune Gastritis: From Parietal Cell Antibodies to H+/K+ ATPase Antibodies
Pepsinogen I levels are another useful marker. Pepsinogen I is produced by the oxyntic glands that autoimmune gastritis destroys, so as parietal cells disappear, pepsinogen I drops. A multicenter study found that low pepsinogen I detected corpus atrophic gastritis with a sensitivity above 90% and specificity above 97%, and could also help distinguish autoimmune atrophy from atrophy caused by H. pylori infection.11PubMed. Serum pepsinogens can help to discriminate between H. pylori-induced and auto-immune atrophic gastritis: Results from a prospective multicenter study The ratio of pepsinogen I to pepsinogen II adds further diagnostic power. One study found that a pepsinogen I/II ratio below about 1.8 had over 90% accuracy for identifying autoimmune gastritis, and high fasting gastrin levels offered similar performance.12Scientific Reports. Relevance of pepsinogen, gastrin, and endoscopic atrophy in the diagnosis of autoimmune gastritis
Elevated fasting gastrin deserves special mention. When parietal cells are destroyed and acid levels drop, the stomach tries to compensate by producing more gastrin, the hormone that signals “make more acid.” Since there are few parietal cells left to respond, gastrin keeps climbing, sometimes reaching very high levels. That elevated gastrin is not just a diagnostic clue; it drives some of the disease’s most worrying complications.
What Endoscopy Reveals
During endoscopy, a stomach with autoimmune gastritis often shows a characteristic pattern: the mucosa in the body looks pale and thin, blood vessels become visible through the thinned lining, and normal gastric folds may be flattened or absent. If intestinal metaplasia has developed, endoscopists using modern high-definition or magnified imaging may see features called light blue crests or white opaque fields. Current guidelines recommend that when these features are present, biopsies should be taken from both the body and the antrum and placed in separately labeled containers, because confirming the pattern of where atrophy does and does not occur is critical for distinguishing autoimmune gastritis from other causes.13PubMed Central. AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review
Under magnification, the mucosal pit pattern in the atrophic body tends to appear oval or slit-shaped in most patients, with tubular and foveolar patterns seen less frequently.14PubMed Central. Endoscopic and clinical characteristics of autoimmune atrophic gastritis: Retrospective study These details may seem granular, but they matter because recognizing the endoscopic appearance of autoimmune gastritis is the first step toward getting the biopsies that confirm it. Many cases have historically been missed on endoscopy because the changes can be subtle in early disease.
Cancer Risk and the Gastrin Connection
Two types of stomach neoplasm are associated with autoimmune gastritis: type 1 gastric neuroendocrine tumors and intestinal-type gastric adenocarcinoma.15PubMed Central. Autoimmunity and Gastric Cancer They arise through different pathways.
The neuroendocrine tumors develop because of that relentless hypergastrinemia. When gastrin levels stay chronically elevated, they stimulate a specific cell type in the stomach lining called enterochromaffin-like (ECL) cells. Over time, these cells proliferate excessively, progressing from hyperplasia to small, usually indolent type 1 neuroendocrine tumors.16PubMed Central. Characterization of neuroendocrine cell hyperplasia in autoimmune gastritis: improving H&E-based diagnosis through systematic training Patients with autoimmune gastritis carry roughly a 13-fold increased risk of developing these tumors compared to the general population.17PubMed. Gastric Carcinoma in Autoimmune Gastritis: A Histopathologic and Molecular Study The good news is that type 1 neuroendocrine tumors are generally slow-growing and rarely metastasize. They are often small polyps found incidentally during surveillance endoscopy and can usually be managed endoscopically.
Gastric adenocarcinoma is the more concerning, though less well-quantified, risk. A recent meta-analysis found that patients with autoimmune gastritis had roughly double the risk of developing gastric cancer overall, with a pooled hazard ratio of about 1.93. But the risk varied sharply by subgroup: patients whose autoimmune gastritis was confirmed histologically had nearly a fivefold elevated risk, and patients who were H. pylori-negative had a higher risk than those who were H. pylori-positive.18PubMed Central. The role of autoimmune gastritis in gastric cancer risk: a systematic review and meta-analysis That last finding is counterintuitive, since H. pylori is the biggest known risk factor for gastric cancer in general. It likely reflects the fact that autoimmune gastritis creates its own independent pathway to cancer through chronic atrophy and intestinal metaplasia, one that does not require the bacterium. The elevated risk is the reason guidelines recommend ongoing endoscopic surveillance.19Current Treatment Options in Gastroenterology. Autoimmune Gastritis: Update and New Perspectives in Therapeutic Management
Autoimmune Gastritis Rarely Travels Alone
If you have autoimmune gastritis, the odds are good that your immune system is also attacking something else. The most common companion condition is autoimmune thyroid disease, particularly Hashimoto’s thyroiditis. The overlap is so well established that it has its own name: the thyrogastric syndrome, first described in the 1960s. Autoimmune thyroid disease shows up in roughly 10 to 40% of patients with autoimmune gastritis, and going the other direction, about 40% of people with autoimmune gastritis also have Hashimoto’s.20PubMed Central. Hashimoto’s Thyroiditis and Autoimmune Gastritis
A study that screened patients with autoimmune thyroid disease specifically for stomach problems found atrophic body gastritis in about 35% of them, confirmed by biopsy. The prevalence increased with age, from 29% in patients aged 20–40 to 45% in those over 60. Most of those cases were associated with Hashimoto’s thyroiditis, though some occurred with Graves’ disease or atrophic thyroiditis.21Archives of Internal Medicine. Atrophic Body Gastritis in Patients With Autoimmune Thyroid Disease: An Underdiagnosed Association The practical takeaway is that if you have autoimmune thyroid disease and develop unexplained anemia or low iron, autoimmune gastritis should be on the list of suspects. And the reverse is true: a new diagnosis of autoimmune gastritis should prompt thyroid screening.
Beyond thyroid disease, autoimmune gastritis can appear as part of autoimmune polyendocrine syndromes, where multiple endocrine glands are targeted. Type 1 diabetes and vitiligo are among the other autoimmune conditions reported alongside it.22PubMed Central. A Case Report of Autoimmune Gastritis Associated With Polyendocrine Syndrome Type III Mimicking Refractory H. pylori Infection
The Altered Stomach Microbiome
A healthy stomach is acidic enough to keep most bacteria at bay. When autoimmune gastritis eliminates acid production, the stomach becomes a more hospitable environment for microbes, and the microbial community shifts substantially. Research has shown that people with autoimmune gastritis harbor a different gastric microbiome than people with a normal acidic stomach.23PubMed Central. Autoimmune Gastritis and Gastric Microbiota
A study comparing the stomach microbiota in different hypochlorhydric conditions found that autoimmune gastritis patients had high bacterial diversity and abundance, with Streptococcus species dominating. The microbial profile was distinct from what you see in atrophic gastritis caused by H. pylori, even though both conditions result in low acid.24PubMed Central. Comparison of the human gastric microbiota in hypochlorhydric states arising as a result of Helicobacter pylori-induced atrophic gastritis, autoimmune atrophic gastritis and proton pump inhibitor use This is still an evolving area of research, and no one yet knows whether the altered microbiome is just a bystander effect of low acid or whether it actively contributes to the progression toward metaplasia and cancer. But it does mean that the stomach in autoimmune gastritis is a fundamentally changed environment, not just a less acidic one.
When It Happens in Children
Autoimmune gastritis is typically thought of as a disease of middle-aged and older adults, but it does occur in children, and it is probably more common than the literature suggests. Pediatric cases follow the same basic pattern as adult ones: iron-deficiency anemia is the most frequent presenting symptom, and the diagnosis is usually delayed because no one expects a child to have autoimmune destruction of the stomach lining.
A study reviewing over 14,000 pediatric gastric biopsies found autoimmune gastritis in only 22 children, a prevalence of about 0.15%. The median age at diagnosis was about 11, nearly 70% were girls, and most had at least one other autoimmune condition.25PubMed. Pediatric autoimmune gastritis: clinical correlates and histologic features A separate series of 33 pediatric patients confirmed that iron-deficiency anemia was the presenting problem in 75% of cases, and about a quarter already had intestinal-type or pseudo-pyloric metaplasia at the time of diagnosis. One patient in that group developed a type 1 neuroendocrine tumor, and no patients showed endoscopic or histologic improvement during follow-up, underscoring the disease’s progressive nature even in young people.26PubMed. Clinical characteristics and outcomes of pediatric patients with autoimmune gastritis
The rarity of pediatric cases may partly be an artifact of underdiagnosis. Two case reports of children aged 12 and 17 who presented with iron-deficiency anemia and no family history of autoimmune disease illustrate the point: in both cases, the diagnosis was delayed until biopsy happened to show the characteristic pattern of oxyntic gland atrophy.27PubMed Central. Autoimmune Gastritis in the Pediatric Age: An Underestimated Condition Report of Two Cases and Review These cases are a reminder that persistent, unexplained iron-deficiency anemia in a child, especially one who already has another autoimmune disease, warrants a look at the stomach.
Living With Symptoms Day to Day
The symptoms of autoimmune gastritis can be deceptively vague. Many patients experience upper gastrointestinal complaints like bloating, early fullness, nausea, and epigastric discomfort, but these overlap heavily with garden-variety dyspepsia, making them easy to dismiss. Others feel surprisingly little stomach-related distress and instead present with the downstream effects of malabsorption: fatigue from iron or B12 deficiency, brain fog, weakness, or numbness and tingling in the extremities.28PubMed Central. Paradoxical association between dyspepsia and autoimmune chronic atrophic gastritis: Insights into mechanisms, pathophysiology, and treatment options
Upper gastrointestinal symptoms can significantly affect quality of life and require their own management strategies separate from treating the nutritional deficiencies.29PubMed Central. A Comprehensive Review of Upper Gastrointestinal Symptom Management in Autoimmune Gastritis: Current Insights and Future Directions One complication is that proton pump inhibitors, the default treatment for many upper GI complaints, suppress exactly the acid production that autoimmune gastritis is already destroying. Using them long-term in someone with autoimmune gastritis may mask laboratory changes, complicate the diagnostic picture, and further reduce an already-compromised ability to absorb nutrients. The paradox is that a patient’s stomach symptoms may feel acid-related when in fact they stem from too little acid, not too much.
For most patients, ongoing management involves lifelong monitoring of iron and B12 levels with supplementation as needed, periodic endoscopy to watch for metaplasia or neoplasia, and screening for associated autoimmune conditions like thyroid disease. There is currently no treatment that reverses the autoimmune destruction itself; management is about replacing what the lost parietal cells can no longer provide and catching complications early.